Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YAZ for Moderate Truncal Acne Vulgaris
NCT00722761Phase 3Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Apr 2009
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ethinyl estradiol + drospirenone in acne vulgaris, sponsored by Massachusetts General Hospital. Started Apr 2009; status: completed.
02
Drugs
ethinyl estradiol + drospirenone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT00722761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00722761.